{"id":672,"date":"2026-10-01T14:45:06","date_gmt":"2026-10-01T14:45:06","guid":{"rendered":"https:\/\/minervainstitute.fi\/?page_id=672"},"modified":"2026-10-08T13:08:28","modified_gmt":"2026-10-08T13:08:28","slug":"avhandlingar-fran-minerva-institutet","status":"publish","type":"page","link":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/","title":{"rendered":"Avhandlingar fr\u00e5n Minerva Institutet"},"content":{"rendered":"<div class=\"acf-hero wp-block-acf-hero\">\n        <section\n        class=\"bg-brand-light-blue text-brand-dark-blue pb-15 pt-(--header-height) min-h-119 flex h-full flex-col justify-end px-4 lg:px-20 lg:pb-20\">\n        <div class=\"max-w-8xl mx-auto w-full\">\n            <div class=\"mt-16.5 lg:mt-19 flex flex-col gap-y-6\">\n                                    <h1>Avhandlingar fra\u030an Minerva Institutet<\/h1>\n                                                            <\/div>\n        <\/div>\n    <\/section>\n    <\/div>\n    \n\n<div class=\"acf-content wp-block-acf-content\">\n        <section class=\"max-w-8xl relative mx-auto px-4 lg:px-20\" data-top-margin=\"regular\"\n            data-bottom-margin=\"regular\">\n                            <div class=\"wysiwyg\">\n                    <h2><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-50\" src=\"https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1.jpg\" alt=\"\" width=\"2361\" height=\"1099\" srcset=\"https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1.jpg 2361w, https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1-300x140.jpg 300w, https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1-1024x477.jpg 1024w, https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1-768x357.jpg 768w, https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1-1536x715.jpg 1536w, https:\/\/minervainstitute.fi\/wp-content\/uploads\/2026\/10\/vaitokset1-2048x953.jpg 2048w\" sizes=\"(max-width: 2361px) 100vw, 2361px\" \/><br \/>\n2025<\/h2>\n<p>Hannes Frederik Bode: Epigenetics of environmental risk factors for breast cancer in cancer-discordant twin pairs. October 1, 2025.<br \/>\nAbel Szkalisity: Computational techniques in lipid metabolic studies. July 7, 2025.<\/p>\n<p>David Micinski: The actin cytoskeleton and axon initial segment function. March 21, 2025.<\/p>\n<h2>2024<\/h2>\n<p>Vignesh Srinivasan: Novel roles of the protein deubiquitinase USP14 in proteostasis regulation and cell stress responses. October 11, 2024.<\/p>\n<p>Juuso Taskinen: The role of endoplasmic reticulum membrane contact sites in human endothelial cells. October 4, 2024.<\/p>\n<p>Taru Knuutinen: The importance of calcium channels in thyroid cancer. September 27, 2024.<\/p>\n<p>Michelle Renlund-Vikstr\u00f6m: Cardiovascular health in preadolescent children following in-utero exposure to pre-eclampsia. June 7, 2024.<\/p>\n<p>Suneeta Narumanchi: Septin7b and let-7c modulate cardiac function and regeneration in zebrafish. June 5, 2024.<\/p>\n<h2>2023<\/h2>\n<p>Juho Pirhonen: Mechanisms of lipid deposition: Application of novel omics techniques, tissue imaging methods, and their synergistic deployment in lipid research. September 29, 2023.<\/p>\n<p>Pushpa Khanal: Molecular regulation of the dendritic spine initiation. August 11, 2023.<\/p>\n<p>Selina M\u00e4kinen: Send in the signals: Studies on the mechanism of insulin resistance in human skeletal muscle. February 4, 2023.<\/p>\n<h2>2022<\/h2>\n<p>Mari Lahelma: Lifestyle factors and lipid metabolism in non-alcoholic fatty liver disease, the metabolic syndrome, and atherosclerotic cardiovascular disease. December 16, 2022.<\/p>\n<p>Maria Ahonen Mehmeti: Mechanisms of adipocyte dysfunction in metabolic disease and cancer. December 9, 2022.<\/p>\n<h2>2021<\/h2>\n<p>Kien Dang: Diagnostic and prognostic role of expressed KRAS and BRAF mutations in MAPK\/ERK-driven cancers. June 21, 2021.<\/p>\n<p>Annika Koponen: ORP2 &#8211; a lipid-binding protein controlling cellular cholesterol transport and signal transduction. April 1, 2021.<\/p>\n<p>Kecheng Zhou: Crosstalk between sphingolipid metabolism and nutrient signaling: Studies on LAPTM4B. March 4, 2021.<\/p>\n<h2>2020<\/h2>\n<p>Hanna Ruhanen: Hepatic lipid metabolism in cardiometabolic diseases \u2013 protective and adverse effects of genetic variants. October 13, 2020.<\/p>\n<p>Dan Pham Duc: Novel roles of p75 neurotrophin receptor in Low-density lipoprotein receptor regulation and lipid signaling. June 4, 2020.<\/p>\n<p>Veijo Salo: Lipogenic subdomains of the ER: The role of seipin. April 17, 2020.<\/p>\n<p>Amr Abouelezz: The structure and dynamics of the actin cytoskeleton in the axon initial segment. February 28, 2020.<\/p>\n<h2>2019<\/h2>\n<p>Iryna Hlushchenko: Actin regulation in dendritic spines: From synaptic plasticity to animal behavior and neurodevelopmental disorders. August 16, 2019.<\/p>\n<h2>2018<\/h2>\n<p>Panu Luukkonen: Heterogeneity of non-alcoholic fatty liver disease \u2013 Genetic and nutritional modulation of hepatic lipid metabolism. September 7, 2018.<\/p>\n<p>Henriikka Kentala: ORP2 \u2013 A sterol sensor controlling hepatocellular bioenergetics and actin cytoskeletal functions. August 18, 2018<\/p>\n<p>Raghavendra Mysore: Novel molecular regulators of adipose tissue metabolism. May 18, 2018.<\/p>\n<p>Anna Tikka: Characterization of ANGPTL3 deficiency and molecular mechanisms of ANGPTL3 deficiency-induced hypolipodemia. January 19, 2018.<\/p>\n<p>Susanna Lallukka: Non-alcoholic fatty liver disease: The role of insulin resistance, inflammation and the PNPLA3 I148M variant. January 13, 2018.<\/p>\n<h2>2017<\/h2>\n<p>Jenni Hyysalo: Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease. December 16, 2017.<\/p>\n<p>Elina Isokuortti: Non-alcoholic fatty liver disease \u2013 Studies on pathogenesis and diagnosis. October 28, 2017.<\/p>\n<p>Boris Vassilev: Studies on proteins influencing cancer progression and regulating endocytic lipid trafficking. April 28, 2017.<\/p>\n<h2>2016<\/h2>\n<p>Johanna M\u00e4kel\u00e4: Neuroprotective effects of PGC-1\u03b1 activators in dopaminergic neurons. May 20, 2016.<\/p>\n<h2>2015<\/h2>\n<p>Veronica Kalhori: Sphingosine-1-phosphate-evoked invasion of follicular thyroid cancer cells: Evidence for the involvement of HIF-1a, MMP2 and MMP9. September 11, 2015.<\/p>\n<p>Tho Huu Ho: Development of amplification-based technologies for enrichment of nucleic acids with difficult sequences or low-abundance point mutations. February 13, 2015.<\/p>\n<h2>2014<\/h2>\n<p>Alise Hyrskyluoto: Endoplasmic reticulum stress, regulation of autophagy and ubiquitin-proteosome system in cellular models of Huntington&#8217;s Disease. September 12, 2014.<\/p>\n<p>Leena Juurinen: Insulin therapy in type 2 diabetes &#8211; Initiation, impact on liver fat, role of combination therapy with glitazones or glinides. May 16, 2014.<\/p>\n<p>Jere Paavola: Aberrant intracellular calcium cycling in the heart &#8211; Mechanistic insights into catecholaminergic polymorphic ventricular tachycardia and heart failure. March 28, 2014.<\/p>\n<h2>2013<\/h2>\n<p>Anders Eriksson-Paloj\u00e4rvi: Neurohumoral responce and pathophysiologic changes during progresson of mitral reurgitation in the Cavalier King Charles spaniel. November 29, 2013.<\/p>\n<p>Wei Wang: Studies on the transcriptional and enzymatic control of steroid metabolism: Regulation by lysosomal acid lipase, 24-dehydrocholesterol reductace, and amyloid precursor protein. November 28, 2013.<\/p>\n<p>Raili Koivuniemi: Regulation of neural progenitor cell proliferation and fate by proteolytic pathways and inflammatory signals in the brain. September 6, 2013.<\/p>\n<p>You Zhou: Oxysterol binding protein homologues: Novel functions in intracellular transport and adipogenesis. January 25, 2013.<\/p>\n<h2>2012<\/h2>\n<p>Noora Putkonen: Organelle specific mechanism of neuronal cell death. October 26, 2012.<\/p>\n<p>Terhi Vihervaara: The role of oxysterol binding proteins in macrophages. October 5, 2012.<\/p>\n<p>Paulina Skrobuk: Glucose and lipid metabolism in human skeletal muscle. September 7, 2012.<\/p>\n<h2>2011<\/h2>\n<p>Ksenia Sevastianova: Combination antiretroviral therapy-associated lipodystrophy: insights into pathogenesis and treatment. November 25, 2011.<\/p>\n<h2>2010<\/h2>\n<p>P\u00e4ivi Lakkisto: Heme oxygenase-1 in cardiovascular diseases. December 17, 2010.<\/p>\n<p>Minna Kairisalo: Oxidative stress and XIAP signalling in neuronal cells. October 15, 2010.<\/p>\n<p>Sami Reijonen: Endoplasmic reticulum stress and cell death mechanisms in the cell model of Huntington&#8217;s disease. October 8, 2010.<\/p>\n<p>Nina Bergelin: Interactions between sphingosine 1-phosphate and vascular endothelial growth factor signaling in thyroid carcinoma cells. September 17, 2010.<\/p>\n<p>Tero Viitanen: GABAa reseptor mediated signalling in the brain: inhibition, shunting and excitation. June 23, 2010.<\/p>\n<p>Janne Makkonen: Adipose tissue inflammation, liver fat and insulin resistance in humans. June 18, 2010.<\/p>\n<h2>2008<\/h2>\n<p>Anna Kotronen: Liver fat in the metabolic syndrome and type 2 diabetes.<\/p>\n<h2>2007<\/h2>\n<p>Cia Ramstr\u00f6m: Ceramides and DAG as regulators of potassium channel function.<\/p>\n<h2>2006<\/h2>\n<p>Tomas Blom: Sphingolipid-mediated regulation of cellular calcium signaling and survival.<\/p>\n<h2>2005<\/h2>\n<p>Mirja Tiikkainen: Effects of weight loss, rosiglitazone and metformin on liver fat content, insulin resistance and gene expression in adipose tissue\u201d<\/p>\n<h2>2004<\/h2>\n<p>Marjo Tamminen: Vascular and Platelet Function in Insulin Resistance<\/p>\n<p>Esa Lepp\u00e4nen: Experimental basis for standardization of blood specimen collection. (started in Minerva but was completed in Jyv\u00e4skyl\u00e4)<\/p>\n<h2>2003<\/h2>\n<p>Elena Korsheninnikova: Molecular mechanisms of insulin resistance in human skeletal muscle and lipodystrophic adipose tissue. July 4, 2003.<\/p>\n<p>Robert Bergholm: Effects of weight loss, physical training and anti-inflammatory therapy on endothelial function in vivo.<\/p>\n<p>Jussi Sutinen: Pathogenesis and treatment of lipodystrophy in HIV-infected patients receiving highly active antiretroviral therapy.<\/p>\n<h2>2002<\/h2>\n<p>Nina Uhlenius: Angiotensin II and nitric oxide in chronic experimental nephritis.<\/p>\n<h2>2001<\/h2>\n<p>Jukka Westerbacka: Insulin action on large artery stiffness in normal and insulin resistant subjects.<\/p>\n<p>Satu Vehkavaara: Identification and treatment of endothelial dysfunction and cardiovascular risk markers in disorders of glucose metabolism and in postmenopausal women.<\/p>\n<h2>2000<\/h2>\n<p>Beno\u00eet Dugu\u00e9: Variabilit\u00e9 Biologique. Influence des facteurs preanalytiques in vivo (stress physique, stress psychologique, chronobiologie) sur les r\u00e9sultants d\u2019analyses de marqueurs biologiques sanguins et cellulaires.<\/p>\n<h2>1999<\/h2>\n<p>Markus Sundblom: Neuropeptide FF in human blood and cerebrospinal fluid.<\/p>\n<h2>1998<\/h2>\n<p>Leena Karhap\u00e4\u00e4: Effects of caffeine and thimerosal on the regulation of intracellular calsium concentration in GH4C1 rat pituitary cells.<\/p>\n<h2>1997<\/h2>\n<p>Marja-Leena Sirvi\u00f6: Endothelin-1; cardiopulmonal expression, metabolism and regulation of atrial natriuretic peptide release.<\/p>\n<h2>1995<\/h2>\n<p>Antti Virkam\u00e4ki: Mechanism and causes of abnormal carbohydrate metabolism during experimental and natural infections.<\/p>\n<h2>1994<\/h2>\n<p>Outi Saijonmaa: Endothelin-1: Plasma levels in cold pressor test and regulation in endothelial cells.<\/p>\n<p>Karri Helin: Neutral endopeptidase inhibition in experimental heart failure.<\/p>\n<h2>1991<\/h2>\n<p>Sari Tikanoja: Free thyroid hormones in serum: performance of different assay methodologies in thyroid diseases and non-thyroidal illnesses.<\/p>\n<h2>1989<\/h2>\n<p>Per-Henrik Groop: The relationship between gastric inhibitory polypeptide (GIP) and beta-cell function in man.<\/p>\n<p>Tuula Tikkanen: Atrial natriuretic peptide in experimental heart failure.<\/p>\n<p>Kaj Mets\u00e4rinne: Renin substrate in human plasma and amniotic fluid.<\/p>\n<h2>1987<\/h2>\n<p>Kid T\u00f6rnquist: 1,25-dihydroxyvitamin D3 and the secretion of thyrotropin and prolactin from the rat pituitary gland.<\/p>\n<p>Katarina Rosenl\u00f6f: Erythropoietin: receptor and comparison with renin substrate.<\/p>\n<h2>1986<\/h2>\n<p>Virpi Oksanen: Neurosarcoidosis: A clinical, laboratory and neuroradiological study.<\/p>\n<p>Jean-Louis Gu\u00e9ant:<\/p>\n<h2>1984<\/h2>\n<p>Markku M. Nieminen: Renin-Aldosterone axis in man following ingestion of ethanol.<\/p>\n<p>Christel Lamberg-Allardt: Serum 25-hydroxy-vitamin D concentration and vitamin D intake.<\/p>\n<p>Terje Forslund: Induction of rat angiotensin converting enzyme by captopril and enalapril.<\/p>\n<h2>1983<\/h2>\n<p>Ilkka Immonen: Factors affecting human plasma renin substrate concentration with emphasis on estrogens and pregnancy.<\/p>\n<h2>1982<\/h2>\n<p>Jaakko Linkola: Strain differences in water and electrolyte metabolism between alcohol preferring (AA) and alcohol avoiding (ANA) rats.<\/p>\n<p>Tom Petterson: Pleural effusions in infectious, neoplastic and connective tissue diseases. A study of cellular and immunological reactions with emphasis on the role of T and B lymphoytes.<\/p>\n<h2>1981<\/h2>\n<p>Ilkka Kouvonen: Structure of the porcine intestinal intrinsic factor (IF) receptor.<\/p>\n<p>Ilkka Tikkanen: Hypertensive effect of autoimmune nephritis in DOCA-NaCl-treated and in spontaneously hypertensive rats.<\/p>\n<p>Georg Borgstr\u00f6m: Clinical implications of chromosome aberrations in hematologic neoplasia.<\/p>\n<h2>1980<\/h2>\n<p>Carola Gr\u00f6nhagen-Riska: Angiotensin converting enzyme and sarcoidosis.<\/p>\n<p>Fredrika Pekonen: The interaction of thyrotropin with its receptors.<\/p>\n<h2>1978<\/h2>\n<p>Thomas T\u00f6tterman: Thyroid-infiltrating immunocompetent cells in human autoimmune thyroid disease.<\/p>\n<p>George Marcoullis: Soluble and membrane-bound proteins involved in vitamin B12 transport.<\/p>\n<p>Pertti Soveri: Renin in human pregnancy and during oral contraception.<\/p>\n<h2>1975<\/h2>\n<p>Gustav W\u00e4gar: Effect of TSH and cyclic adenosine 3\u00b4, 5\u00b4-monophosphate on thyroidal protein synthesis.<\/p>\n<p>Jim Schr\u00f6der: Passage of blood cells between foetus and mother.<\/p>\n<h2>1974<\/h2>\n<p>Ariel Gordin: Thyrotrophin in human serum; A methodological and clinical study in diseases of the thyroid gland.<\/p>\n<p>Ulf-H\u00e5kan Stenman: Studies on cobalophilin. Vitamin B12-binding proteins of R-type.<\/p>\n<p>Ritva-Kajsa Selander: Kromosomala makromolekylers effekt p\u00e5 vissa akridinderivats absorption och fluorescens.<\/p>\n<h2>1973<\/h2>\n<p>Aldur Eriksson: Human twinning in and around the \u00c5land Islands.<\/p>\n<h2>1972<\/h2>\n<p>Jorma M\u00e4enp\u00e4\u00e4: Hypothyroidism and autoimmune thyroiditis in childhood.<\/p>\n<p>Risto Kala: Venous plasma angiotensin II in man. Diurnal variation and response to various postural stimuli and exercise.<\/p>\n<h2>1971<\/h2>\n<p>Johan Wennstr\u00f6m: Effect of ionizing radiation on the chromosomes in meiotic and mitotic cells.<\/p>\n<p>Frej Fyhrquist: Radioimmunoassay of plasma angiotensin II in patients with hypertension, in renal transplant recipients, and in anephric patients.<\/p>\n<h2>1970<\/h2>\n<p>Johan Edgren: Effect of cysteine on chromosome aberrations induced by radiation of human lymphocytes in vitro.<\/p>\n<h2>1969<\/h2>\n<p>Teddy Weber: Isolation and characterization of a lymphocyte-stimulating leucoagglutinin from red kidney beans. (Phaseolus vulgaris).<\/p>\n<h2>1968<\/h2>\n<p>Rolf Nordman: Endemic goitre in Finland in the light of thyroids of newborn in 1962-1965.<\/p>\n<p>Kristian Liewendahl: Iodochloroxyquinoline and the thyroid gland. Metabolism of iodochloroxyquinoline iodine and its effect on the thyroid iodine metabolism in rats.<\/p>\n<h2>1964<\/h2>\n<p>Kaj Simons: Vitamin B12 binders in human body fluids and blood cells.<\/p>\n<h2>1962<\/h2>\n<p>Albert de la Chapelle: Cytogenetical and clinical observations in female gonadal dysgenesis.<\/p>\n\n                <\/div>\n                    <\/section>\n\n    <\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":666,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-672","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avhandlingar fr\u00e5n Minerva Institutet - Minervainstitutet<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avhandlingar fr\u00e5n Minerva Institutet - Minervainstitutet\" \/>\n<meta property=\"og:url\" content=\"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/\" \/>\n<meta property=\"og:site_name\" content=\"Minervainstitutet\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-08T13:08:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/om-forskningsinstitutet\\\/avhandlingar-fran-minerva-institutet\\\/\",\"url\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/om-forskningsinstitutet\\\/avhandlingar-fran-minerva-institutet\\\/\",\"name\":\"Avhandlingar fr\u00e5n Minerva Institutet - Minervainstitutet\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/#website\"},\"datePublished\":\"2026-10-01T14:45:06+00:00\",\"dateModified\":\"2026-10-08T13:08:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/om-forskningsinstitutet\\\/avhandlingar-fran-minerva-institutet\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/om-forskningsinstitutet\\\/avhandlingar-fran-minerva-institutet\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/om-forskningsinstitutet\\\/avhandlingar-fran-minerva-institutet\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Om oss\",\"item\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/om-forskningsinstitutet\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Avhandlingar fr\u00e5n Minerva Institutet\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/#website\",\"url\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/\",\"name\":\"Minervainstitutet\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/minervainstitute.fi\\\/sv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avhandlingar fr\u00e5n Minerva Institutet - Minervainstitutet","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/","og_locale":"sv_SE","og_type":"article","og_title":"Avhandlingar fr\u00e5n Minerva Institutet - Minervainstitutet","og_url":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/","og_site_name":"Minervainstitutet","article_modified_time":"2026-10-08T13:08:28+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/","url":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/","name":"Avhandlingar fr\u00e5n Minerva Institutet - Minervainstitutet","isPartOf":{"@id":"https:\/\/minervainstitute.fi\/sv\/#website"},"datePublished":"2026-10-01T14:45:06+00:00","dateModified":"2026-10-08T13:08:28+00:00","breadcrumb":{"@id":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/avhandlingar-fran-minerva-institutet\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/minervainstitute.fi\/sv\/"},{"@type":"ListItem","position":2,"name":"Om oss","item":"https:\/\/minervainstitute.fi\/sv\/om-forskningsinstitutet\/"},{"@type":"ListItem","position":3,"name":"Avhandlingar fr\u00e5n Minerva Institutet"}]},{"@type":"WebSite","@id":"https:\/\/minervainstitute.fi\/sv\/#website","url":"https:\/\/minervainstitute.fi\/sv\/","name":"Minervainstitutet","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/minervainstitute.fi\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/pages\/672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/comments?post=672"}],"version-history":[{"count":1,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/pages\/672\/revisions"}],"predecessor-version":[{"id":673,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/pages\/672\/revisions\/673"}],"up":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/pages\/666"}],"wp:attachment":[{"href":"https:\/\/minervainstitute.fi\/sv\/wp-json\/wp\/v2\/media?parent=672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}